E-LIB Suche - Ergebnisse für: Wasmann, Roeland E

1

Determinants of early change in serum creatinine after init..:

Mpofu, Rephaim ; Kawuma, Aida N. ; Wasmann, Roeland E....
British Journal of Clinical Pharmacology. 90 (2024) 5 - p. 1247-1257 , 2024

Link: https://doi.org/10.1111/..

2

Evaluating pediatric tuberculosis dosing guidelines: A mode..:

Galileya, Lufina Tsirizani ; Wasmann, Roeland E. ; Chabala, Chishala...
PLOS Medicine. 20 (2023) 11 - p. e1004303 , 2023

Link: https://doi.org/10.1371/..

3

Population pharmacokinetics of tenofovir given as either te..:

Kawuma, Aida N. ; Wasmann, Roeland E. ; Sinxadi, Phumla...
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 6 - p. 821-830 , 2023

Link: https://doi.org/10.1002/..

4

Pharmacogenetics of tenofovir clearance among Southern Afri..:

Cindi, Zinhle ; Kawuma, Aida N. ; Maartens, Gary...
Pharmacogenetics and Genomics. 33 (2023) 4 - p. 79-87 , 2023

Link: https://doi.org/10.1097/..

5

First Pharmacokinetic Data of Tenofovir Alafenamide Fumarat..:

Waalewijn, Hylke ; Szubert, Alexander J ; Wasmann, Roeland E...
Clinical Infectious Diseases. 77 (2023) 6 - p. 875-882 , 2023

Link: https://doi.org/10.1093/..

6

A model-based approach for a practical dosing strategy for ..:

Wasmann, Roeland E. ; Masini, Tiziana ; Viney, Kerri...
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

Ciprofloxacin Pharmacokinetics After Oral and Intravenous A..:

van Rhee, Koen P. ; Smit, Cornelis ; Wasmann, Roeland E....
Clinical Pharmacokinetics. 61 (2022) 8 - p. 1167-1175 , 2022

Link: https://doi.org/10.1007/..

8

Global estimates and determinants of antituberculosis drug ..:

Gafar, Fajri ; Wasmann, Roeland E. ; McIlleron, Helen M....
European Respiratory Journal. 61 (2022) 3 - p. 2201596 , 2022

Link: https://doi.org/10.1183/..

9

Pharmacogenetics of Dolutegravir Plasma Exposure Among Sout..:

Cindi, Zinhle ; Kawuma, Aida N ; Maartens, Gary...
The Journal of Infectious Diseases. 226 (2022) 9 - p. 1616-1625 , 2022

Link: https://doi.org/10.1093/..

10

Drug–drug interaction between rifabutin and dolutegravir: A..:

Kawuma, Aida N. ; Wasmann, Roeland E. ; Dooley, Kelly E...
British Journal of Clinical Pharmacology. 89 (2022) 3 - p. 1216-1221 , 2022

Link: https://doi.org/10.1111/..

11

Population pharmacokinetics of esomeprazole in patients wit..:

Gebreyesus, Manna Semere ; Decloedt, Eric H. ; Cluver, Catherine A....
British Journal of Clinical Pharmacology. 88 (2022) 10 - p. 4639-4645 , 2022

Link: https://doi.org/10.1111/..

12

Total bodyweight and sex both drive pharmacokinetic variabi..:

Chen, Lu ; van Rhee, Koen P ; Wasmann, Roeland E...
Journal of Antimicrobial Chemotherapy. 77 (2022) 8 - p. 2217-2226 , 2022

Link: https://doi.org/10.1093/..

13

Dolutegravir pharmacokinetics during co-administration with..:

Kawuma, Aida N ; Walimbwa, Stephen I ; Pillai, Goonaseelan (Colin)...
Journal of Antimicrobial Chemotherapy. 76 (2021) 5 - p. 1269-1272 , 2021

Link: https://doi.org/10.1093/..

14

Constructing a representative in‐silico population for paed..:

Wasmann, Roeland E. ; Svensson, Elin M. ; Walker, A. Sarah..
British Journal of Clinical Pharmacology. 87 (2021) 7 - p. 2847-2854 , 2021

Link: https://doi.org/10.1111/..

15

Optimizing Dosing and Fixed-Dose Combinations of Rifampicin..:

Denti, Paolo ; Wasmann, Roeland E ; van Rie, Annelies...
Clinical Infectious Diseases. 75 (2021) 1 - p. 141-151 , 2021

Link: https://doi.org/10.1093/..